Value of pentraxin-3 and galectin-3 in acute coronary syndrome: a short-term prospective cohort study

Conclusion:
Pentraxin-3 and galectin-3 hold much promise in the ACS population as prognostic biomarkers.

Source: Therapeutic Advances in Cardiovascular Disease - October 9, 2015 Category: Cardiology Authors: George, M., Shanmugam, E., Srivatsan, V., Vasanth, K., Ramraj, B., Rajaram, M., Jena, A., Sridhar, A., Chaudhury, M., Kaliappan, I. Tags: Original Research Source Type: research